Morphological heterogeneity of oral salivary gland carcinomas: A clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 4, 2011, Pages 336-348

  Schwarz, Stephan ^a   Müller, Maximilian ^a   Ettl, Tobias ^b   Stockmann, Philipp ^a   Zenk, Johannes ^a   Agaimy, Abbas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Acinic cell carcinoma; Adenoid cystic carcinoma; Oral salivary gland carcinoma; Polymorphous low grade adenocarcinoma

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 7; KRT5 PROTEIN, HUMAN; KRT7 PROTEIN, HUMAN; MIB1 PROTEIN, HUMAN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CHEMISTRY; CHROMOSOME 11; CHROMOSOME 19; COMPARATIVE STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SALIVARY GLAND TUMOR; TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ACINAR CELL; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIER ESTIMATE; KERATIN-5; KERATIN-7; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; SALIVARY GLAND NEOPLASMS; TIME FACTORS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 80051652161     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Al-Rawi NH and Talabani NG. Squamous cell carcinoma of the oral cavity: a case series analysis of clinical presentation and histological grading of 1,425 cases from Iraq. Clin Oral Investig 2008; 12: 15-18.
2. Eveson JW and Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 1985; 146: 51-58.
3. Buchner A, Merrell PW and Carpenter WM. Relative frequency of intra-oral minor salivary gland tumors: a study of 380 cases from northern California and comparison to reports from other parts of the world. J Oral Pathol Med 2007; 36: 207-214.
4. Dhanuthai K, Boonadulyarat M, Jaengjongdee T and Jiruedee K. A clinico-pathologic study of 311 intra-oral salivary gland tumors in Thais. J Oral Pathol Med 2009; 38: 495-500.
5. Jaber MA. Intraoral minor salivary gland tumors: a review of 75 cases in a Libyan population. Int J Oral Maxillofac Surg 2006; 35: 150-154.
6. Toida M, Shimokawa K, Makita H, Kato K, Kobayashi A, Kusunoki Y, Hatakeyama D, Fujitsuka H, Yamashita T and Shibata T. Intraoral minor salivary gland tumors: a clinicopathological study of 82 cases. Int J Oral Maxillofac Surg 2005; 34: 528-532.
7. Yih WY, Kratochvil FJ and Stewart JC. Intraoral minor salivary gland neoplasms: review of 213 cases. J Oral Maxillofac Surg 2005; 63: 805-810.
8. Anavi Y, Calderon S, Gal G and Sandbank J. Intraoral acinic cell carcinoma. Ann Dent 1993; 52: 26-29.
9. Bircan S, Kayaselcuk F, Yavuz H and Tuncer I. Acinic cell carcinoma with follicular pattern of the soft palate. Pathol Res Pract 2004; 200: 575-579.
10. Crivelini MM, de Sousa SO and de Araujo VC. Immunohistochemical study of acinic cell carcinoma of minor salivary gland. Oral Oncol 1997; 33: 204-208.
11. Freedman PD and Lumerman H. Lobular carcinoma of intraoral minor salivary gland origin. Report of twelve cases. Oral Surg Oral Med Oral Pathol 1983; 56: 157-166.
12. Batsakis JG, Pinkston GR, Luna MA, Byers RM, Sciubba JJ and Tillery GW. Adenocarcinomas of the oral cavity: a clinicopathologic study of terminal duct carcinomas. J Laryngol Otol 1983; 97: 825-835.
13. Evans HL and Batsakis JG. Polymorphous lowgrade adenocarcinoma of minor salivary glands. A study of 14 cases of a distinctive neoplasm. Cancer 1984; 53: 935-942.
14. Luna MA and Wenig BM. Polymorphous lowgrade adenocarcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. p. 223-224.
15. Perez-Ordonez B, Linkov I and Huvos AG. Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 17 cases with emphasis on cell differentiation. Histopathology 1998; 32: 521-529.
16. Araujo V, Sousa S, Jaeger M, Jaeger R, Loyola A, Crivelini M and Araujo N. Characterization of the cellular component of polymorphous lowgrade adenocarcinoma by immunohistochemistry and electron microscopy. Oral Oncol 1999; 35: 164-172.
17. Araujo VC, Loducca SV, Sousa SO, Williams DM and Araujo NS. The cribriform features of adenoid cystic carcinoma and polymorphous lowgrade adenocarcinoma: cytokeratin and integrin expression. Ann Diagn Pathol 2001; 5: 330-334.
18. Epivatianos A, Iordanides S, Zaraboukas T and Antoniades D. Adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of minor salivary glands: a comparative immunohistochemical study using the epithelial membrane and carcinoembryonic antibodies. Oral Dis 2005; 11: 175-180.
19. Loducca SV, Raitz R, Araujo NS and Araujo VC. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: distinct architectural composition revealed by collagen IV, laminin and their integrin ligands (alpha2beta1 and alpha3beta1). Histopathology 2000; 37: 118-123.
20. Arduino PG, Carrozzo M, Pagano M, Broccoletti R, Scully C and Gandolfo S. Immunohistochemical expression of basement membrane proteins of verrucous carcinoma of the oral mucosa. Clin Oral Investig 2009;
21. Darling MR, Schneider JW and Phillips VM. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Oral Oncol 2002; 38: 641-645.
22. Prasad ML, Barbacioru CC, Rawal YB, Husein O and Wen P. Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Mod Pathol 2008; 21: 105-114.
23. Edwards PC, Bhuiya T and Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 613-619.
24. Ferrazzo KL, Alves SM, Jr., Santos E, Martins MT and de Sousa SM. Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. Oral Oncol 2007; 43: 580-585.
25. Ferrazzo KL, Neto MM, dos Santos E, dos Santos Pinto D and de Sousa SO. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. J Oral Pathol Med 2009; 38: 701-707.
26. Beltran D, Faquin WC, Gallagher G and August M. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg 2006; 64: 415-423.
27. Edwards PC, Bhuiya T and Kelsch RD. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous lowgrade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 586-593.
28. Epivatianos A, Poulopoulos A, Dimitrakopoulos I, Andreadis D, Nomikos A, Vlahou S, Papazoglou G and Barbatis C. Application of alphasmooth muscle actin and c-kit in the differential diagnosis of adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Oral Oncol 2007; 43: 67-76.
29. Penner CR, Folpe AL and Budnick SD. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol 2002; 15: 687-691.
30. Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE and Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008; 53: 567-577.
31. Evans HL and Luna MA. Polymorphous lowgrade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas. Am J Surg Pathol 2000; 24: 1319-1328.
32. El-Naggar AK and Huvos AG. Adenoid cystic carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. p. 221-222.
33. Ellis G and Simpson RHW. Acinic cell carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. p. 216-218.
34. Goode RK and El-Naggar AK. Mucoepidermoid carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. p. 219-220.
35. Auclair P and van der Waal JE. Adenocarcinoma, not otherwise specified. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. p. 238-239.
36. Schwarz S, Stiegler C, Muller M, Ettl T, Brockhoff G, Zenk J and Agaimy A. Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation. Histopathology 2011; 58: 557-570.
37. Simpson RH, Clarke TJ, Sarsfield PT, Gluckman PG and Babajews AV. Polymorphous low-grade adenocarcinoma of the salivary glands: a clinicopathological comparison with adenoid cystic carcinoma. Histopathology 1991; 19: 121-129.
38. Skalova A, Simpson RH, Lehtonen H and Leivo I. Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Pathol Res Pract 1997; 193: 695-703.